Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADMS
5176
DELISTED
Adamas Pharmaceuticals
ADMS
| $16K | ﹤0.01% |
6,135
-1,509
| -20% | -$4.43K |
|
|
INWK
5177
DELISTED
InnerWorkings, Inc.
INWK
| $16K | ﹤0.01% |
11,857
-2,722
| -19% | -$3.62K |
|
5178
CALL
Axos Financial
AX
$5.77B
| $15K | ﹤0.01% |
700
-19,000
| -96% | -$386K |
|
5179
Bridgford Foods
BRID
$57.6M
| $15K | ﹤0.01% |
948
+374
| +65% | +$6.5K |
|
5180
CALL
Chemours
CC
$2.5B
| $15K | ﹤0.01% |
1,000
-1,000
| -50% | -$12.6K |
|
5181
Invesco DB Base Metals Fund
DBB
$312M
| $15K | ﹤0.01% |
1,073
| – | – |
|
5182
CALL
Levi Strauss
LEVI
$9.44B
| $15K | ﹤0.01% |
1,100
-20,500
| -95% | -$269K |
|
5183
Marchex
MCHX
$76.2M
| $15K | ﹤0.01% |
9,660
-2,187
| -18% | -$3.31K |
|
5184
Medallion Financial
MFIN
$229M
| $15K | ﹤0.01% |
5,542
-1,299
| -19% | -$3.12K |
|
|
NGD
5185
CALL
DELISTED
New Gold Inc
NGD
| $15K | ﹤0.01% |
10,800
+4,400
| +69% | +$4.42K |
|
5186
Prospect Capital
PSEC
$1.07B
| $15K | ﹤0.01% |
+2,963
| New | +$13.9K |
|
5187
Value Line
VALU
$321M
| $15K | ﹤0.01% |
567
+214
| +61% | +$6.12K |
|
|
CMLS
5188
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $15K | ﹤0.01% |
3,878
-882
| -19% | -$4.02K |
|
|
SPPI
5189
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $15K | ﹤0.01% |
4,500
-500
| -10% | -$1.46K |
|
|
CFMS
5190
DELISTED
Conformis, Inc. Common Stock
CFMS
| $15K | ﹤0.01% |
740
-116
| -14% | -$2.42K |
|
|
HNP
5191
DELISTED
Huaneng Power Intl, Inc.
HNP
| $15K | ﹤0.01% |
1,000
-2,236
| -69% | -$32.7K |
|
|
RLH
5192
DELISTED
Red Lions Hotel Corporation
RLH
| $15K | ﹤0.01% |
6,473
-1,501
| -19% | -$2.69K |
|
|
AMAG
5193
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
| $15K | ﹤0.01% |
2,000
-7,700
| -79% | -$58.9K |
|
|
GNC
5194
CALL
DELISTED
GNC Holdings, Inc.
GNC
| $15K | ﹤0.01% |
27,800
-1,300
| -4% | -$815 |
|
5195
PUT
Hecla Mining
HL
$9.47B
| $14K | ﹤0.01% |
4,400
-27,300
| -86% | -$75.4K |
|
5196
CALL
Host Hotels & Resorts
HST
$17.2B
| $14K | ﹤0.01% |
1,300
-2,100
| -62% | -$24.1K |
|
5197
Lee Enterprises
LEE
$172M
| $14K | ﹤0.01% |
1,438
-337
| -19% | -$3.22K |
|
5198
McEwen Inc
MUX
$1.03B
| $14K | ﹤0.01% |
1,396
| – | – |
|
5199
NLI Holdings
NL
$281M
| $14K | ﹤0.01% |
4,250
+1,493
| +54% | +$4.63K |
|
|
PW
5200
Power REIT
PW
$3.01M
| $14K | ﹤0.01% |
+50
| New | +$9.84K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.